Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126003511 | 12600351 | 1 | I | 20141106 | 20160721 | 20160727 | 20160727 | EXP | PHHY2016ES101761 | SANDOZ | 66.00 | YR | M | Y | 0.00000 | 20160727 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126003511 | 12600351 | 1 | SS | SINTROM | ACENOCOUMAROL | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 126003511 | 12600351 | 2 | PS | ALOPURINOL | ALLOPURINOL | 1 | Oral | UNK UNK, QD | Y | 70268 | QD | ||||||||
| 126003511 | 12600351 | 3 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | UNK UNK, QD | Y | 0 | QD | ||||||||
| 126003511 | 12600351 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | UNK UNK, QD | Y | 0 | QD | ||||||||
| 126003511 | 12600351 | 5 | SS | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | UNK, QD | Y | 0 | QD | ||||||||
| 126003511 | 12600351 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 126003511 | 12600351 | 7 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 126003511 | 12600351 | 8 | C | IVABRADINE | IVABRADINE | 1 | Unknown | U | 0 | ||||||||||
| 126003511 | 12600351 | 9 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | U | 0 | ||||||||||
| 126003511 | 12600351 | 10 | C | PREGABALINE | PREGABALIN | 1 | Unknown | U | 0 | ||||||||||
| 126003511 | 12600351 | 11 | C | INSULIN LISPRO | INSULIN LISPRO | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126003511 | 12600351 | 1 | Atrial fibrillation |
| 126003511 | 12600351 | 2 | Product used for unknown indication |
| 126003511 | 12600351 | 3 | Product used for unknown indication |
| 126003511 | 12600351 | 4 | Product used for unknown indication |
| 126003511 | 12600351 | 5 | Hyperlipidaemia |
| 126003511 | 12600351 | 6 | Product used for unknown indication |
| 126003511 | 12600351 | 7 | Product used for unknown indication |
| 126003511 | 12600351 | 8 | Product used for unknown indication |
| 126003511 | 12600351 | 9 | Product used for unknown indication |
| 126003511 | 12600351 | 10 | Product used for unknown indication |
| 126003511 | 12600351 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126003511 | 12600351 | LT |
| 126003511 | 12600351 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126003511 | 12600351 | Basal ganglia haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126003511 | 12600351 | 1 | 20140122 | 20141106 | 0 | |
| 126003511 | 12600351 | 5 | 2010 | 20141106 | 0 |